BMEZ (BlackRock Health Sciences Term Trust)
Insider Trading Activity
Every open-market purchase and sale reported by BMEZ officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | H Erin Xie | — | MIXED | — | — |
| 2026-02-03 | Xiang Liu | — | MIXED | — | — |
| 2025-12-22 | Robert W Fairbairn | Director | Sell | — | — |
| 2025-04-22 | Saba Capital Management, L.P. | 10%+ Owner | U | — | — |
| 2025-02-04 | Xiang Liu | — | MIXED | — | — |
| 2025-02-04 | H Erin Xie | — | MIXED | — | — |
| 2025-02-04 | Christopher Accettella | — | MIXED | — | — |
| 2025-02-04 | Kyle McClements | — | MIXED | — | — |
| 2024-10-17 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-10-15 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-10-04 | Christopher Accettella | — | Buy | — | — |
| 2024-10-03 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-10-01 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-09-30 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-09-26 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-09-24 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-09-23 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-09-19 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-04-30 | Kyle McClements | — | Buy | — | — |
| 2024-04-03 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-04-01 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-03-27 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-03-06 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-03-04 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-02-29 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-02-27 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-02-22 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-02-21 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-02-15 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-02-12 | H Erin Xie | — | A | — | — |
| 2024-02-12 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-02-08 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-02-05 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-02-02 | Christopher Accettella | — | A | — | — |
| 2024-02-02 | Kyle McClements | — | A | — | — |
| 2024-02-02 | H Erin Xie | — | MIXED | — | — |
| 2024-02-02 | Xiang Liu | — | A | — | — |
| 2024-02-01 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-01-31 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-01-26 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-01-24 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-01-23 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-01-18 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2024-01-16 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2024-01-12 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2023-12-21 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2023-12-18 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2023-12-14 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2023-12-13 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2023-12-11 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 20,670,916 | — |
| — | — | 25,676 | — |
| — | — | 4,509 | — |
| — | — | 4,273 | — |
| — | Director | 1,987 | — |
| — | Director | 500 | — |
| — | Director | 50 | — |
| — | Director | 0 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BMEZ quote page; the site-wide leaderboard is on the insider transactions hub.